Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
8.74
+1.00 (12.92%)
At close: Dec 19, 2025, 4:00 PM EST
8.84
+0.10 (1.09%)
After-hours: Dec 19, 2025, 7:58 PM EST
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $623.67 million as of December 19, 2025. Its market cap has increased by 239.23% in one year.
Market Cap
623.67M
Enterprise Value
441.06M
1-Year Change
239.23%
Ranking
Category
Stock Price
$8.74
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $623.67M, a decrease of -20.34%. That is a compound annual growth rate of -5.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 623.67M | 302.74% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
| Oct 21, 2021 | 782.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |